GlassScriptPhysician profile
Cory Michael Bunch
NPI 1235213661
$1,919.77
in general payments reported to CMS, 2019-2025
12 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $435 · 2023: $426 · 2024: $559 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.53 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $381.25 | 2023-2025 | |
| Glaxosmithkline, LLC. | $378.41 | 2022-2025 | Trelegy Ellipta, Nucala |
| Kaleo, INC. | $353.88 | 2022-2023 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $301.87 | 2022-2025 | Airsupra, Fasenra, Tezspire |
| Alk-Abello, INC | $123.80 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $111.00 | 2023 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $68.33 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $61.78 | 2025 | |
| Optinose US, INC. | $54.38 | 2024 | |
| Paratek Pharmaceuticals, INC. | $36.07 | 2025 | Xhance |
| Amgen INC. | $34.00 | 2025 | |
| Hikma Pharmaceuticals USA | $15.00 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Bunch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.